Welcome to Mælandsmo's Group
The research group is studying biological and therapeutic aspects of the metastatic process, the principle cause of death in cancer patients. Our goal is to extend the knowledge about how the individual steps in this complicated process are regulated, and subsequently use this information for identification of potential target molecules that can be utilized in cancer therapy.
Professor Gunhild M. Mælandsmo, who is the administrative group leader.
The group is member of the Center for Research Based Innovation, Cancer Stem Cell Innovation Center (CAST)., and the K.G. Jebsen centre for Breast Cancer Research http://www.med.uio.no/klinmed/forskning/sentre/kgj-brystkreftforskning/om/kontakt/.
The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 18 79(Mælandsmo) Fax: +47 22 78 17 95
Jun 17, 2013
Jun 14, 2013
International approaches to personalized cancer medicine
Jun 5, 2013
Metastasis: biology and therapy group
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Breast Cancer Res, 15 (1), R16 (in press)